BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12642431)

  • 1. Salmeterol (Serevent) asthma trial halted early.
    Wooltorton E
    CMAJ; 2003 Mar; 168(6):738. PubMed ID: 12642431
    [No Abstract]   [Full Text] [Related]  

  • 2. Summaries for patients. What are the risks of using inhaled long-acting beta-agonist medications for the relief of asthma?
    Ann Intern Med; 2006 Jun; 144(12):I30. PubMed ID: 16785474
    [No Abstract]   [Full Text] [Related]  

  • 3. No association of catastrophic events with Advair.
    Yancey SW; Knobil K; Kral K
    Am J Med; 2010 Oct; 123(10):e15; author reply e17. PubMed ID: 20920673
    [No Abstract]   [Full Text] [Related]  

  • 4. Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events.
    Cates CJ; Lasserson TJ
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007695. PubMed ID: 19821436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long acting beta 2 agonists and the risk of life threatening asthma.
    Ernst P
    Thorax; 1998 Jan; 53(1):1-2. PubMed ID: 9577513
    [No Abstract]   [Full Text] [Related]  

  • 6. Comments on the Salmeterol Multicenter Asthma Research Trial.
    Seymour SM; Sullivan EJ; Chowdhury BA; Meyer RJ; Davi RC
    Chest; 2006 Sep; 130(3):930-1; author reply 931. PubMed ID: 16963702
    [No Abstract]   [Full Text] [Related]  

  • 7. Asthma mortality and beta-agonists.
    Skorodin MS
    Chest; 1995 Dec; 108(6):1768. PubMed ID: 7497807
    [No Abstract]   [Full Text] [Related]  

  • 8. The controversy over long-acting beta agonists: examining the evidence.
    Lang DM
    Cleve Clin J Med; 2006 Nov; 73(11):973-6, 978, 981-4 passim. PubMed ID: 17128539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-acting beta-agonists, tachyphylaxis, and corticosteroids.
    Sears MR
    Chest; 1996 Apr; 109(4):862-4. PubMed ID: 8635359
    [No Abstract]   [Full Text] [Related]  

  • 10. Cause of death in the SMART Trial.
    Williams C
    Chest; 2006 Sep; 130(3):929-30; author reply 930. PubMed ID: 16963700
    [No Abstract]   [Full Text] [Related]  

  • 11. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.
    Cates CJ; Lasserson TJ; Jaeschke R
    Cochrane Database Syst Rev; 2009 Jul; (3):CD006922. PubMed ID: 19588410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [More asthma death cases with beta-2-antagonists: with inhaled corticosteroids on the safe side?].
    Wepner U
    MMW Fortschr Med; 2007 Dec; 149(49-50):20. PubMed ID: 18240436
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety of long-acting beta-agonists in asthma: a review.
    Oppenheimer J; Nelson HS
    Curr Opin Pulm Med; 2008 Jan; 14(1):64-9. PubMed ID: 18043277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why SMART about second-line treatment when first-line treatment is being ignored?
    Currie GP
    Chest; 2006 Sep; 130(3):929; author reply 929. PubMed ID: 16963701
    [No Abstract]   [Full Text] [Related]  

  • 15. Beta2 déjà vu.
    O'Byrne PM; Adelroth E
    Chest; 2006 Jan; 129(1):3-5. PubMed ID: 16424402
    [No Abstract]   [Full Text] [Related]  

  • 16. Asthma exacerbations in patients taking regular salmeterol, or salbutamol for symptoms.
    Shepherd GL; Jenkins WJ; Alexander J
    Lancet; 1991 Jun; 337(8754):1424. PubMed ID: 1674807
    [No Abstract]   [Full Text] [Related]  

  • 17. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths.
    Salpeter SR; Buckley NS; Ormiston TM; Salpeter EE
    Ann Intern Med; 2006 Jun; 144(12):904-12. PubMed ID: 16754916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C; Wu EQ; Ray S; Colice GL
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of long-acting beta-agonists: urgent need to clear the air remains.
    Beasley R; Martinez FD; Hackshaw A; Rabe KF; Sterk PJ; Djukanovic R
    Eur Respir J; 2009 Jan; 33(1):3-5. PubMed ID: 19118222
    [No Abstract]   [Full Text] [Related]  

  • 20. Regular treatment with salmeterol for chronic asthma: serious adverse events.
    Cates CJ; Cates MJ
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006363. PubMed ID: 18646149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.